| Line Item | 2025-11-01 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $268.0M | +20.2% | +272.1% |
| Cost of Revenue | $87.0M | +19.6% | +228.0% |
| Gross Profit | $181.0M | +20.4% | +297.8% |
| R&D Expense | $57.9M | +10.4% | +82.5% |
| SG&A Expense | $44.3M | +19.2% | +99.9% |
| Operating Income | $78.8M | +29.7% | +1037.3% |
| Pre-tax Income | $83.7M | +29.4% | +2227.8% |
| Income Tax | $1.0M | -18.6% | +259.2% |
| Net Income | $82.6M | +30.3% | +2055.9% |
| EPS (Basic) | $0.47 | +27.0% | +1666.7% |
| EPS (Diluted) | $0.44 | +29.4% | +1566.7% |
| Line Item | 2025-11-01 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $567.6M | +158.4% | +137.2% |
| Short-term Investments | $246.0M | -5.4% | +71.2% |
| Accounts Receivable | $245.2M | +35.3% | +199.8% |
| Inventory | $150.2M | +28.7% | +313.6% |
| Current Assets | $1.24B | +54.7% | +131.0% |
| Total Assets | $1.45B |
| Line Item | 2025-11-01 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $115.8M | +113.8% | — |
| Capital Expenditures | $26.0M | +822.0% | — |
| Investing Cash Flow | -$159.6M | -135.3% | — |
| Financing Cash Flow | $374.9M | — | — |
| Free Cash Flow | $89.8M | +74.9% | — |
| +127.0% |
| Current Liabilities | $140.4M | +29.5% | +182.7% |
| Total Liabilities | $163.2M | +31.8% | +131.0% |
| Stockholders' Equity | $1.29B | +64.6% | +126.5% |